Medicare coverage depends on why the medication is prescribed, the exact drug, and the program being used. If you do not qualify for the Medicare GLP-1 Bridge, you may still have other coverage, assistance, or cash-pay options.
The key distinction: Regular Medicare Part D generally excludes drugs used only for weight loss. A separate temporary program, called the Medicare GLP-1 Bridge, offers certain GLP-1 medications to eligible people for a $50 copay per 28- or 30-day supply. Approval is required.
Before you read further...
Many people assume a drug is either “covered” or “not covered” by Medicare. With GLP-1 medications, it is much more complicated.
The same medication may be:
- Covered through your Medicare Part D plan,
- Available through the Medicare GLP-1 Bridge program,
- Or not covered by either program.
The deciding factor is often the medical reason your doctor prescribed it—not just the medication’s name.
Start with these three questions:
- Is the drug treating a condition Part D can cover? If so, ask the plan about regular Part D coverage.
- Is it being used for weight management only? Check whether you meet Medicare GLP-1 Bridge rules.
- Neither path works? Review the alternatives chart below with your prescriber and pharmacist.
Jump to a section
- Before you read further
- When regular Part D may cover a GLP-1
- The Medicare GLP-1 Bridge
- Who may qualify for Bridge?
- How the Bridge process works
- Bridge costs and limits
- Options if Bridge or Part D does not work
- Formulary exceptions
- What if coverage is denied? Formulary exceptions
- Compounding and online-pharmacy safety
- What happens after 2027?
- Additional information
When regular Part D may cover a GLP-1
Medicare Part D generally excludes drugs when they are used only for weight loss. However, a GLP-1 may qualify for regular Part D coverage when the exact medication is prescribed for another medically accepted use. Examples may include:
- Type 2 diabetes
- Reducing cardiovascular risk for a patient who meets the approved indication
- Moderate-to-severe obstructive sleep apnea in an adult with obesity
- Noncirrhotic MASH with moderate-to-advanced liver scarring
Coverage is not automatic. The medication, diagnosis, dose, and plan formulary must all line up. A plan may also require prior authorization, step therapy, or a quantity limit.
Outside the six protected drug classes, Part D plans generally do not have to cover every medication in a category. That means one plan may cover a particular GLP-1 for an eligible use while another plan may prefer a different drug or apply additional requirements.
What to ask: “What diagnosis and FDA-approved use is this prescription treating? Will you check my exact Part D plan for this drug, strength, and use before I fill it?”
Do not switch between Ozempic, Mounjaro, Wegovy, Zepbound, or another drug based on coverage alone. They are not interchangeable in every situation. Your prescriber must decide whether a different medication is appropriate.
The diagnosis matters: If a prescription is for cardiovascular risk reduction, including when weight management is also a goal, CMS says the request should go through Part D when the drug has that approved indication. A Part D denial does not automatically make someone eligible for Bridge.
The Medicare GLP-1 Bridge
The Medicare GLP-1 Bridge is a temporary program for certain adults with Medicare drug coverage who use an included GLP-1 for weight management. It began July 1, 2026, and is scheduled to continue through December 31, 2027.
| Bridge basics | Current rule |
|---|---|
| Included drugs | Foundayo tablets; Wegovy tablets and injections, including Wegovy HD; and Zepbound KwikPen. Zepbound single-dose pens and vials are not included. |
| Cost | $50 for each covered 28- or 30-day supply. The payment does not count toward the Part D deductible or out-of-pocket limit. |
| Basic eligibility | Age 18 or older, eligible Medicare drug coverage, prior authorization, use for weight management with lifestyle support, and the required BMI and health criteria when GLP-1 treatment began. |
| Clinical criteria | BMI 35 or higher; BMI 30 or higher with certain listed conditions; or BMI 27 or higher with certain listed conditions. Use Medicare’s eligibility questions for the full list. |
| Not eligible through Bridge | People already receiving a GLP-1 through Part D, and people whose GLP-1 is being used for type 2 diabetes, moderate-to-severe sleep apnea, or qualifying fatty liver disease. Those uses should be checked through the Part D plan. |
- Ask your prescriber which route applies: regular Part D or Bridge.
- Have the prescription sent to the pharmacy. For Bridge, the pharmacy must submit the initial Bridge claim before the prescriber submits prior authorization.
- Your prescriber completes the approval request when requested.
- After approval, ask the pharmacy to reprocess the claim and confirm the price before pickup.
Bridge is temporary: Current approval lasts through December 31, 2027, unless the beneficiary changes GLP-1 drugs. Coverage after that date is not guaranteed. The broader BALANCE model is not launching in Medicare in 2027.
Check Bridge eligibility Call 1-800-MEDICARE
Who may qualify for Bridge?
You must be at least 18, have an eligible type of Medicare drug coverage, and receive prior authorization. Eligible coverage can include a stand-alone Part D plan, a Medicare Advantage plan with drug coverage, a Special Needs Plan, an employer or union group waiver plan, or the LI NET program.
Your prescriber must confirm that the medication is being used for weight management with ongoing nutrition and physical activity support, unless physical activity is not clinically appropriate.
You must also have met one of these criteria when GLP-1 treatment began:
- BMI 35 or higher.
- BMI 30 or higher plus heart failure with preserved ejection fraction, uncontrolled hypertension, or chronic kidney disease stage 3a or higher.
- BMI 27 or higher plus prediabetes, a previous heart attack or stroke, or peripheral artery disease with symptoms.
For Bridge, uncontrolled hypertension means systolic pressure above 140 or diastolic pressure above 90 despite treatment with two blood-pressure medicines.
HeyMOE tip: If you have already lost weight while taking a GLP-1, ask your prescriber to review your starting BMI and medical records. CMS uses eligibility when treatment began, including treatment that started before Medicare enrollment or before Bridge launched.
Bridge exclusions: Medicare directs people with type 2 diabetes, moderate-to-severe obstructive sleep apnea, or qualifying fatty liver disease to their Part D plan. People already receiving a GLP-1 through Part D are also not eligible for Bridge.
How the Bridge process works
- Talk with your prescriber. Review the diagnosis, treatment history, starting BMI, and whether regular Part D or Bridge is the correct route.
- Have the prescription sent to the pharmacy. If Bridge is appropriate, ask the office to indicate that the prescription is for Bridge weight management.
- Let the pharmacy submit the Bridge claim first. The initial claim establishes the patient in the Bridge system. A rejection saying prior authorization is required can be a normal step.
- The prescriber submits prior authorization. The office completes the request electronically or by fax after the pharmacy initiates the process.
- Confirm approval and price. Medicare sends a decision letter. Ask the pharmacy to reprocess the prescription after approval.
If the request gets stuck: Ask whether the pharmacy submitted the first claim to Medicare GLP-1 Bridge. A prior authorization sent too early can produce a “patient not found” error. The prescriber can call 855-273-0102, Monday–Friday, 8 a.m.–7 p.m. Eastern.
Instructions for the medical office: CMS prescriber guide.
Bridge costs and limits
- $50 for each covered 28- or 30-day supply. Bridge does not offer 90-day fills.
- No Part D deductible applies.
- The $50 payment does not count toward the Part D deductible or out-of-pocket limit and will not appear on the Part D Explanation of Benefits.
- Extra Help does not reduce the $50 Bridge cost.
- The Medicare Prescription Payment Plan cannot spread the Bridge cost across future months.
- Zepbound KwikPen needles cost extra. CMS says they are not covered through Bridge and should not be billed to Part D for this use.
An approval generally covers refills and dose changes through December 31, 2027. Switching to another GLP-1 requires a new prior authorization.
Budget separately: Twelve monthly fills would total $600 in Bridge payments, plus any separately purchased needles or other supplies. Those payments do not move you closer to your Part D out-of-pocket limit.
OPTIONS IF BRIDGE PROGRAM DOES NOT WORK FOR YOU
The best alternative depends on the medication, diagnosis, finances, and level of medical support you need. The chart is a starting point, not a promise of eligibility, coverage, or savings.
| Option | Can a person with Medicare use it? | When it may help | Savings and important limits |
|---|---|---|---|
| Regular Part D coverage | Yes | A GLP-1 is prescribed for a Part D-coverable use and the plan’s rules are met. | Plan price varies by formulary, tier, deductible, pharmacy, and restrictions. |
| Medicare GLP-1 Bridge | Yes, if eligible | Eligible Part D beneficiaries using an included drug for weight management. | $50 per covered 28- or 30-day supply. Temporary through December 31, 2027. |
| Switch to a covered medication | Yes | A different medication is medically appropriate and covered for the diagnosis being treated. | May provide plan coverage. Your prescriber must approve the treatment change. |
| Pharmacy discount programs | Yes, as a cash purchase | Comparing cash prices for an uncovered medication. | Savings vary. The discount is used instead of Part D, and the purchase does not count toward the Part D deductible or out-of-pocket limit. |
| Manufacturer cash-price or direct-pay program | Sometimes | A manufacturer offers a cash option for the exact product. | Price and Medicare eligibility vary. Confirm medication, dose, pharmacy, shipping, and all fees. |
| Manufacturer savings card | Usually no | Generally designed for people with eligible commercial insurance. | Most exclude people enrolled in Medicare or another federal health program. Read the current terms. |
| Manufacturer patient assistance program | Sometimes | People who meet the program’s medication, insurance, income, and residency rules. | Medication may be low cost or no cost if approved. Rules differ by manufacturer and can change. |
| National telehealth provider | Yes | Someone wants remote medical support and understands the full cash price. | Compare membership, visit, lab, medication, supply, and shipping charges. Confirm whether the product is FDA-approved or compounded. |
| Compounded GLP-1 | Only in limited circumstances | A prescriber determines that the patient’s medical needs cannot be met by an FDA-approved drug. | May cost less, but it is not an FDA-approved generic. FDA does not review compounded products for safety, effectiveness, or quality before marketing. |
| Existing HSA or available FSA funds | Sometimes | Paying eligible out-of-pocket prescription expenses with tax-advantaged funds. | Tax savings only; this does not reduce the price. Medicare enrollment stops new HSA contributions, but existing HSA funds can still be used for qualified expenses. FSA rules depend on the employer plan. |
| International mail-order pharmacy | Not a routine lawful option | People researching foreign prices should understand the legal and safety risks before ordering. | FDA says personal importation is illegal in most circumstances and recommends obtaining medicines from legal U.S. sources. |
| Formulary exception | Yes, for an eligible Part D use | The plan does not cover an otherwise Part D-eligible drug or applies a restriction the prescriber believes should be waived. | Could result in plan coverage if approved. It cannot override Medicare’s exclusion for a drug used only for weight loss. |
Compare the full monthly cost: Include the medication, visits, membership fee, labs, needles or other supplies, and shipping. Ask whether the price changes when the dose changes.
Formulary exceptions
What if coverage is denied?
For a regular Part D request: Ask why the claim was denied. Your prescriber may need to supply medical records, complete prior authorization, or request a formulary exception for a drug missing from the plan’s covered-drug list.
If your medication is being used for a condition that is eligible for Part D, but your plan does not cover the drug or applies a coverage rule, ask your prescriber whether an exception is appropriate. The prescriber generally must explain why covered options would not work as well or would cause adverse effects.
For a standard coverage request, the plan generally must issue a decision within 72 hours after it receives the prescriber’s supporting statement. For an expedited request, the timeframe is generally 24 hours. If the request is denied, the decision notice explains how to appeal.
For a Bridge request: Ask your prescriber to review the denial reason. CMS allows the office to correct and resubmit a request for re-review if it believes the decision was made in error.
An exception has limits: It cannot make a drug covered by regular Part D when the drug is being used only for weight loss. If a Bridge request is denied, ask the prescriber to review the Bridge denial reason and whether the request should be corrected and resubmitted.
Read: How formulary exceptions work
Compounding and online-pharmacy safety
Do not buy based on price alone. Avoid a seller that does not require a prescription, will not identify the dispensing pharmacy, claims its compounded product is the same as an FDA-approved drug, or offers prices that seem too good to be true.
FDA says compounded GLP-1 drugs should be used only when a patient’s medical needs cannot be met by an FDA-approved drug. Use a state-licensed pharmacy, confirm the exact ingredient and concentration, and ask who will answer questions after the medication arrives.
FDA also says importing prescription drugs for personal use is illegal in most circumstances and that it cannot ensure the safety or effectiveness of medicines purchased from foreign sources. A website comparison is not proof that ordering a drug is lawful or safe.
What happens after 2027?
CMS originally described Bridge as a temporary pathway leading to a broader model called BALANCE. CMS now says BALANCE is not launching in Medicare in 2027. Instead, Bridge is scheduled to continue through December 31, 2027 while CMS collects additional information.
There is no guaranteed permanent Medicare GLP-1 weight-loss benefit after that date. Before Bridge ends, ask your prescriber about a continued-treatment plan and check for updated Medicare rules, manufacturer programs, and Part D options.
Program updates: CMS: BALANCE model.
Check these links for additional information
The first three links below are third-party comparisons, not HeyMOE or government endorsements. Services, rankings, prices, and eligibility rules can change.
- Forbes ranking of telehealth platforms for getting weight loss medications—compare telehealth platforms
- Comparing Canadian pharmacies—review the comparison
- Comparing prescription discount programs—review discount-program comparisons
- Medicare: Weight loss drugs and Bridge eligibility
- CMS: Medicare GLP-1 Bridge
- Medicare: Help with drug costs
- Medicare: Find pharmaceutical assistance programs
- CMS: Part D coverage exceptions
- FDA: Concerns with unapproved GLP-1 drugs
- IRS: HSA and FSA rules
- FDA: Personal importation rules
Last reviewed: October 14, 2026. Program rules, drug lists, assistance programs, prices, and plan coverage can change. Your prescriber determines whether treatment is appropriate; Medicare, the Bridge program, or your plan determines coverage; and the pharmacy confirms the price.
Was this article helpful?
That’s Great!
Thank you for your feedback
Sorry! We couldn't be helpful
Thank you for your feedback
Feedback sent
We appreciate your effort and will try to fix the article